Bucher, V.; Graf, H.; Zander, J.; Liebchen, U.; Hackner, D.; Gräfe, C.; Bender, M.; Zoller, M.; Scharf, C.
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK Study. Biomedicines 2024, 12, 2436.
https://doi.org/10.3390/biomedicines12112436
AMA Style
Bucher V, Graf H, Zander J, Liebchen U, Hackner D, Gräfe C, Bender M, Zoller M, Scharf C.
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK Study. Biomedicines. 2024; 12(11):2436.
https://doi.org/10.3390/biomedicines12112436
Chicago/Turabian Style
Bucher, Veronika, Helen Graf, Johannes Zander, Uwe Liebchen, Danilo Hackner, Caroline Gräfe, Martin Bender, Michael Zoller, and Christina Scharf.
2024. "Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK Study" Biomedicines 12, no. 11: 2436.
https://doi.org/10.3390/biomedicines12112436
APA Style
Bucher, V., Graf, H., Zander, J., Liebchen, U., Hackner, D., Gräfe, C., Bender, M., Zoller, M., & Scharf, C.
(2024). Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK Study. Biomedicines, 12(11), 2436.
https://doi.org/10.3390/biomedicines12112436